Cardiology
RSSArticles
-
Safety of Testosterone Replacement Questioned
In a study of men in the Veterans Affairs health care system with low serum testosterone levels, the use of testosterone therapy was associated with an increased risk of mortality, myocardial infarction, or ischemic stroke. -
Clinical Briefs By Louis Kuritzky
-
Modern Radiation Therapy and ADT for High-risk Prostate Cancer Result in Improved Survival
Historically, men with high-risk prostate cancer were believed to have low survival rates after definitive treatment with either surgery or radiation. However, long-term results of dose-escalated radiotherapy of doses ≥ 75.6 Gy, along with long-term androgen deprivation therapy (ADT), demonstrate 5-year survival rate of 92%, 5-year biochemical control rate of 82%, and symptomatic local failure rate of 0%. Death from prostate cancer was only 5.5% at 10 years in men treated with high-dose radiation therapy and ADT. -
Pharmacology Update: Riociguat Tablets (Adempas®)
-
ECG Review: Does the AV Block Get Worse?
-
Diagnosis and Management of Respiratory Syncytial Virus in the Emergency Department
RSV occurs primarily in the winter months in the United States and is a cause of significant morbidity and mortality, particularly in the very young and very old. -
Who Should be Referred for Advanced Heart Failure Care?
-
Clinical Cardiology Alert - Full April 2014 Issue in PDF
-
Value of the Physical Examination in Heart Failure
-
Should Catheter Ablation be First-Line Therapy for Patients with Paroxysmal AF?
Atrial fibrillation (AF) is common and catheter ablation has become widely available.